Porcine reproductive and respiratory syndrome (PRRS) is one of the major diseases affecting the global swine industry. Current methods to control this viral disease are insufficient or pose safety concerns; therefore, there is a need for a safer and more effective vaccine against PRRS. In this study, we designed a chimeric nanoparticle vaccine through genetic fusion of an epitope composed of portions from two PRRS viral proteins, M and GP5, with lumazine synthase from Aquifex aeolicus . Transient expression in the leaves of Nicotiana benthamiana plants resulted in soluble levels around 0.18 mg·g −1 of plant fresh weight. This fusion protein assembles into nanoparticle structures surface‐displaying the PRRS epitope and is efficiently glycosylated with oligomannose N‐linked glycans. A mouse immunization trial was conducted using this protein as well as a previously described protein consisting of the same epitope displayed on a modified tobacco mosaic virus coat protein, and both vaccine candidates induced epitope‐specific antibodies. This study demonstrates the feasibility of protein nanoparticle‐based vaccines against PRRS produced in plants and lays the foundation for future studies to evaluate vaccine efficacy in pigs.
11 August 2026 in Biotechnology and Bioengineering
Protein nanoparticles offer an innovative approach to next‐generation subunit vaccine development by displaying antigenic sequences on the nanoparticle surface. Compared to traditional subunit vaccines, protein nanoparticle vaccines often show improved interaction with the immune system due to their particulate size and repetitive epitope display. Ferritin from Helicobacter pylori assembles into a spherical shape composed of 24 subunits that can display foreign peptides on its surface for use in vaccine development. Surface display can be achieved via genetic fusion of sequences encoding antigenic peptides to the N‐terminus of the protein. Ferritin‐based vaccine candidates have been increasingly explored through recombinant production in bacteria, insect cells, and mammalian cells; however, this protein had not been produced in plants before. We expressed ferritin from H. pylori in Nicotiana benthamiana and targeted it to the secretory pathway. We also modified ferritin to prevent glycosylation. We found this ferritin variant accumulates to over 0.2 mg/g fresh weight in plant leaves, and genetic fusion of a viral glyco‐epitope to this protein significantly increases accumulation. We determined that the epitope is efficiently glycosylated and the protein fusion assembles into characteristic nanoparticles. We found that this fusion protein shows similar iron mineralization to the unmodified ferritin, and introducing a two amino acid substitution decreased this function. This study provides the groundwork for further exploration of plant‐produced ferritin as a scaffold for vaccine development.
Porcine reproductive and respiratory syndrome (PRRS) is a disease leading to spontaneous abortions and stillbirths in sows and lowered life quality and expectancy in growing pigs. PRRS is prevalent worldwide and has significant economic impacts to swine industries around the globe. Co-expression of the two most abundant proteins in the viral envelope, the matrix protein (M) and glycosylated protein 5 (GP5), can produce a neutralizing immune response for the virus providing a potentially effective subunit vaccine against the disease, but these proteins are difficult to express. The goal of this research was to display antigenic portions of the M and GP5 proteins on the surface of tobacco mosaic virus-like particles. A modified tobacco mosaic virus coat protein (TMVc) was transiently expressed inNicotiana benthamianaleaves and targeted to three subcellular compartments along the secretory pathway to introduce glycosylation patterns important for M-GP5 epitope immunogenicity. We found that accumulation levels in the apoplast were similar to the ER and the vacuole. Because glycans present on plant apoplastic proteins are closest to those present on PRRSV proteins, a TMVc-M-GP5 fusion construct was targeted to the apoplast and accumulated at over 0.5 mg/g of plant fresh weight. TMVc virus-like particles self-assembled in plant cells and surface-displayed the M-GP5 epitope, as visualized by transmission electron microscopy and immunogold localization. These promising findings lay the foundation for immunogenicity and protective-immunity studies in animals to examine the efficacy of this vaccine candidate as a measure to control PRRS.